Corient Private Wealth
USPH icon

Corient Private Wealth’s US Physical Therapy USPH Stock Holding History

Corient Private Wealth’s Portfolio USPH Stock Details USPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Sell
3,031
-2,145
-41% -$146K ﹤0.01% 2786
2026
Q1 		$388K Buy
5,176
+347
+7% +$28.4K ﹤0.01% 2171
2025
Q4 		$377K Sell
4,829
-690
-13% -$56K ﹤0.01% 2026
2025
Q3 		$469K Buy
5,519
+571
+12% +$45.7K ﹤0.01% 1831
2025
Q2 		$387K Buy
4,948
+1,194
+32% +$88K ﹤0.01% 1846
2025
Q1 		$272K Sell
3,754
-142
-4% -$11.9K ﹤0.01% 1906
2024
Q4 		$346K Sell
3,896
-598
-13% -$53.3K ﹤0.01% 1822
2024
Q3 		$380K Buy
4,494
+40
+0.9% +$3.55K ﹤0.01% 1891
2024
Q2 		$412K Buy
4,454
+336
+8% +$34K ﹤0.01% 1746
2024
Q1 		$465K Buy
4,118
+11
+0.3% +$1.1K ﹤0.01% 1667
2023
Q4 		$383K Buy
4,107
+1,284
+45% +$113K ﹤0.01% 1753
2023
Q3 		$259K Buy
2,823
+79
+3% +$8.49K ﹤0.01% 1810
2023
Q2 		$333K Buy
2,744
+250
+10% +$27K ﹤0.01% 1645
2023
Q1 		$244K Buy
+2,494
New +$238K ﹤0.01% 1702

Other funds holding USPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
SAM
Southernsun Asset Management Memphis, Tennessee $743M AUM 34.03% 1-Year Est. Return

Corient Private Wealth's USPH Position: Q2 2026 in Review

Corient Private Wealth reduced its US Physical Therapy (USPH) stake by 41% in Q2 2026, selling an estimated $146K and leaving 3,031 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #2786.

Corient Private Wealth first reported a position in USPH in Q1 2023 and has held it in 14 quarters since. The position peaked at $469K in Q3 2025. 217 funds tracked by Wall St. Rank hold USPH as of Q2 2026.

  • Corient Private Wealth held 3,031 shares of US Physical Therapy worth $208K as of Q2 2026.
  • Corient Private Wealth sold 2,145 US Physical Therapy shares in Q2 2026, an estimated $146K.
  • US Physical Therapy made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2786 holding.
  • Corient Private Wealth first reported a position in US Physical Therapy in Q1 2023 and has held it in 14 quarters since.
  • Corient Private Wealth's US Physical Therapy position peaked at $469K in Q3 2025.
  • 217 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.